These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30234864)

  • 21. Synthesis and Evaluation of Caged siRNA with Terminal Single Vitamin E Modification.
    Yang J; Yu L; Zhang L; Long X; Ji Y; Tang X
    Curr Protoc Nucleic Acid Chem; 2016 Dec; 67():16.6.1-16.6.22. PubMed ID: 27911495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
    Kim SH; Mok H; Jeong JH; Kim SW; Park TG
    Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenovirus-delivered antisense RNA and shRNA exhibit different silencing efficiencies for the endogenous transforming growth factor-beta (TGF-beta) type II receptor.
    Ogorelkova M; Zwaagstra J; Elahi SM; Dias C; Guilbaut C; Lo R; Collins C; Jaramillo M; Mullick A; O'Connor-McCourt M; Massie B
    Oligonucleotides; 2006; 16(1):2-14. PubMed ID: 16584291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved serum stability and biophysical properties of siRNAs following chemical modifications.
    Cho IS; Kim J; Lim DH; Ahn HC; Kim H; Lee KB; Lee YS
    Biotechnol Lett; 2008 Nov; 30(11):1901-8. PubMed ID: 18575806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing.
    Dua P; Yoo JW; Kim S; Lee DK
    Mol Ther; 2011 Sep; 19(9):1676-87. PubMed ID: 21673662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted delivery and enhanced gene-silencing activity of centrally modified folic acid-siRNA conjugates.
    Salim L; Islam G; Desaulniers JP
    Nucleic Acids Res; 2020 Jan; 48(1):75-85. PubMed ID: 31777918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs.
    Hamada M; Ohtsuka T; Kawaida R; Koizumi M; Morita K; Furukawa H; Imanishi T; Miyagishi M; Taira K
    Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):301-9. PubMed ID: 12477280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Light-activated RNA interference.
    Shah S; Rangarajan S; Friedman SH
    Angew Chem Int Ed Engl; 2005 Feb; 44(9):1328-32. PubMed ID: 15643658
    [No Abstract]   [Full Text] [Related]  

  • 29. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
    Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the Mechanisms of Light-Triggered siRNA Release from Nanoshells for Temporal Control Over Gene Regulation.
    Riley RS; Dang MN; Billingsley MM; Abraham B; Gundlach L; Day ES
    Nano Lett; 2018 Jun; 18(6):3565-3570. PubMed ID: 29701993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific residues at every third position of siRNA shape its efficient RNAi activity.
    Katoh T; Suzuki T
    Nucleic Acids Res; 2007; 35(4):e27. PubMed ID: 17259216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longer 19-base pair short interfering RNA duplexes rather than shorter duplexes trigger RNA interference.
    Sierant M; Kazmierczak-Baranska J; Paduszynska A; Sobczak M; Pietkiewicz A; Nawrot B
    Oligonucleotides; 2010 Aug; 20(4):199-206. PubMed ID: 20575617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the RNA Interference Activity Using Central Mismatched siRNAs and Acyclic Threoninol Nucleic Acids (aTNA) Units.
    Alagia A; Terrazas M; Eritja R
    Molecules; 2015 Apr; 20(5):7602-19. PubMed ID: 25919280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caged circular antisense oligonucleotides for photomodulation of RNA digestion and gene expression in cells.
    Wu L; Wang Y; Wu J; Lv C; Wang J; Tang X
    Nucleic Acids Res; 2013 Jan; 41(1):677-86. PubMed ID: 23104375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumoral gene silencing by receptor-targeted combinatorial siRNA polyplexes.
    Lee DJ; He D; Kessel E; Padari K; Kempter S; Lächelt U; Rädler JO; Pooga M; Wagner E
    J Control Release; 2016 Dec; 244(Pt B):280-291. PubMed ID: 27287890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA interference with 2',4'-bridged nucleic acid analogues.
    Abdur Rahman SM; Sato H; Tsuda N; Haitani S; Narukawa K; Imanishi T; Obika S
    Bioorg Med Chem; 2010 May; 18(10):3474-80. PubMed ID: 20427190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of sequence features that predict competition potency of siRNAs.
    Li X; Yoo JW; Lee JH; Hahn Y; Kim S; Lee DK
    Biochem Biophys Res Commun; 2010 Jul; 398(1):92-7. PubMed ID: 20558136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA interference by mixtures of siRNAs prepared using custom oligonucleotide arrays.
    Oleinikov AV; Zhao J; Gray MD
    Nucleic Acids Res; 2005 Jun; 33(10):e92. PubMed ID: 15942024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNAi in human cells: basic structural and functional features of small interfering RNA.
    Chiu YL; Rana TM
    Mol Cell; 2002 Sep; 10(3):549-61. PubMed ID: 12408823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.